Other Information.
+Added: During the three months ended March 31, 2024, no director or “officer” (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
The exhibits filed or furnished as part of this Quarterly Report on Form 10-Q are set forth on the Exhibit Index, which Exhibit Index is incorporated herein by reference.
EXHIBIT INDEX
−Removed: 4.1 Common Stock Purchase Warrant, dated July 10, 2023, issued to Armistice Capital Master Fund Ltd.
−Removed: (Exhibit 4.1 to the Company’s Form 10-Q filed August 14, 2023).
−Removed: 10.1 *+ Amended and Restated Products Purchase Agreement dated September 18, 2023 by and between Rockwell Medical, Inc.
−Removed: and DaVita Inc.
−Removed: 10.2 Letter Agreement, dated July 10, 2023, by and between Rockwell Medical, Inc.
−Removed: and Armistice Capital Master Fund Ltd.
−Removed: (Exhibit 10.1 to the Company’s Form 10-Q filed August 14, 2023).
−Removed: 10.3 Asset Purchase Agreement dated July 10, 2023 by and between Rockwell Medical, Inc.
−Removed: and Evoqua Water Technologies LLC.
−Removed: (Exhibit 10.2 to the Company’s Form 10-Q filed August 14, 2023).
+Added: 4.1 Form of January 2024 Warrant to Purchase Common Stock issued to Innovatus Life Sciences Lending Fund I, LP (Exhibit 4.1 to the Company's Form 8-K filed on January 8, 2024).
+Added: 10.1 Third Amendment to and Restatement of Loan and Security Agreement, dated January 1, 2024, by and among the Company, Rockwell Transportation, Inc., Innovatus Life Sciences Lending Fund I, LP and the lenders party thereto (Exhibit 10.1 to the Company's Form 8-K filed on January 8, 2024).
31.1* Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
7 unchanged sentences
101.PRE* XBRL Taxonomy Extension Presentation Linkbase
−Removed: 104* The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline XBRL (included as Exhibit 101)
+Added: 104* The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, formatted in Inline XBRL (included as Exhibit 101)
* Filed herewith
** Furnished herewith and not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act
−Removed: + Certain confidential portions of this exhibit were omitted by means of marking such portions with asterisks because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ROCKWELL MEDICAL, INC.
−Removed: November 14, 2023 /s/ Mark Strobeck
+Added: May 14, 2024 /s/ Mark Strobeck
Mark Strobeck, Ph.D.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.